New ARCADIA Consortium Builds on MAPJAG to Redefine Remission in Arthritis
The ARCADIA arthritis remission study has been awarded £3 million in funding from Arthritis UK, bringing together leading centres across the UK and Europe to address a key challenge in inflammatory arthritis: how to accurately define when remission has truly been achieved. Running from November 2025 to October 2030, the ARCADIA consortium will focus on […]